Islam, M.R.; Markatos, C.; Pirmettis, I.; Papadopoulos, M.; Karageorgos, V.; Liapakis, G.; Fahmy, H.
Design, Synthesis, and Biological Evaluations of Novel Thiazolo[4,5-d]pyrimidine Corticotropin Releasing Factor (CRF) Receptor Antagonists as Potential Treatments for Stress Related Disorders and Congenital Adrenal Hyperplasia (CAH). Molecules 2024, 29, 3647.
https://doi.org/10.3390/molecules29153647
AMA Style
Islam MR, Markatos C, Pirmettis I, Papadopoulos M, Karageorgos V, Liapakis G, Fahmy H.
Design, Synthesis, and Biological Evaluations of Novel Thiazolo[4,5-d]pyrimidine Corticotropin Releasing Factor (CRF) Receptor Antagonists as Potential Treatments for Stress Related Disorders and Congenital Adrenal Hyperplasia (CAH). Molecules. 2024; 29(15):3647.
https://doi.org/10.3390/molecules29153647
Chicago/Turabian Style
Islam, Md Rabiul, Christos Markatos, Ioannis Pirmettis, Minas Papadopoulos, Vlasios Karageorgos, George Liapakis, and Hesham Fahmy.
2024. "Design, Synthesis, and Biological Evaluations of Novel Thiazolo[4,5-d]pyrimidine Corticotropin Releasing Factor (CRF) Receptor Antagonists as Potential Treatments for Stress Related Disorders and Congenital Adrenal Hyperplasia (CAH)" Molecules 29, no. 15: 3647.
https://doi.org/10.3390/molecules29153647
APA Style
Islam, M. R., Markatos, C., Pirmettis, I., Papadopoulos, M., Karageorgos, V., Liapakis, G., & Fahmy, H.
(2024). Design, Synthesis, and Biological Evaluations of Novel Thiazolo[4,5-d]pyrimidine Corticotropin Releasing Factor (CRF) Receptor Antagonists as Potential Treatments for Stress Related Disorders and Congenital Adrenal Hyperplasia (CAH). Molecules, 29(15), 3647.
https://doi.org/10.3390/molecules29153647
